EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of cancer treatment with excess heart age among five-year young breast cancer survivors

Jacqueline B Vo, Shoshana Rosenberg, Bessie X Zhang, Craig Snow, Greg Kirkner, Philip D Poorvu, Rachel Gaither, Kathryn J Ruddy, Rulla M Tamimi, Jeffrey M Peppercorn, Lidia Schapira, Virginia F Borges und 3 weitere

Journal of Cancer Survivorship · 2026-02 · 20 (1) · 189-197

DOI: 10.1007/s11764-024-01645-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Survivorship, online erschienen am 15.07.2024. Verfasst von Jacqueline B Vo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Prevention Fellowship Program, Division of Cancer Epidemiology & Genetics, National Cancer Institute, 9609 Medical Center Drive, 7E532, Bethes…. Hauptthemen laut MEDLINE: Breast Neoplasms, Cancer Survivors, Cardiovascular Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Prevention Fellowship Program at the National Cancer Institute, The Young Women’s Breast Cancer Study is funded in part by Susan G. Komen and Breast Cancer Research Foundation, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Data evaluating cardiovascular disease (CVD) risk by cancer treatment among young women (≤ 40 years) with breast cancer are limited.

Methods

Among 372 five-year breast cancer survivors aged 30–40 years from the Young Women's Breast Cancer Study, we assessed the association of cancer treatments (anthracyclines, trastuzumab, radiation/laterality, endocrine therapy) and excess heart age (difference between predicted 10-year CVD risk as assessed by adapted Framingham Risk Score and chronological age), prevalent elevated excess heart age (≥ 2 years), and worsening excess heart age (change of ≥ 2 excess heart age years) at breast cancer diagnosis and two- and five-year follow-up using multivariable linear and logistic regressions.

Results

Most women had stage I or II (79%), ER + (71%), or PR + (65%) breast cancer. At diagnosis, women had little excess heart age by treatment receipt (range of means = -0.52,0.91 years). Left-sided radiation (β = 2.49,SE = 0.96,p = 0.01) was associated with higher excess heart age at five-year follow-up. For prevalent elevated excess heart age (two-year = 26%;five-year = 27%), women treated with right-sided radiation had increased risk at two-years (OR = 2.17,95%CI = 1.12–4.19), yet at five-years, associations were observed after any radiation (OR = 1.92,95%CI = 1.09–3.41), especially after left-sided (OR = 2.13,95%CI = 1.09–3.41) radiation. No associations were observed between systemic treatments and prevalent elevated excess heart age or any treatments with worsening excess heart age.

Conclusions

Among young breast cancer survivors, radiation, but not other cancer treatments, was associated with elevated excess heart age. Implications for cancer survivors CVD risk tools that incorporate cancer treatment, such as radiation, are needed to identify high risk young breast cancer survivors given the long survivorship and long latency of cardiovascular disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCancer SurvivorsCardiovascular DiseasesHumansFemaleAdultFollow-Up Studies

Stichwörter der Autor:innen

Breast cancer survivorshipCardiovascular disease riskExcess heart ageYoung breast cancer

Autor:innen und Institutionen

  • Cancer Prevention Fellowship Program, Division of Cancer Epidemiology & Genetics, National Cancer Institute, 9609 Medical Center Drive, 7E532, Bethesda, Rockville, MD, 20906, USA. jacqueline.vo@nih.gov.
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
  • Harvard Medical School, Boston, MA, USA.
  • Department of Epidemiology, Brown University School of Public Health, Providence, RI, USA.
  • Department of Oncology, Mayo Clinic, Rochester, MN, USA.

Förderung

  • Cancer Prevention Fellowship Program at the National Cancer Institute
  • The Young Women’s Breast Cancer Study is funded in part by Susan G. Komen and Breast Cancer Research Foundation
  • National Cancer Institute

Zitieren

APA

Vo, J. B., Rosenberg, S., Zhang, B. X., Snow, C., Kirkner, G., Poorvu, P. D., Gaither, R., Ruddy, K. J., Tamimi, R. M., Peppercorn, J. M., Schapira, L., Borges, V. F., Come, S. E., Nohria, A., & Partridge, A. H. (2026). Association of cancer treatment with excess heart age among five-year young breast cancer survivors. Journal of Cancer Survivorship, 20(1), 189-197. https://doi.org/10.1007/s11764-024-01645-9

Vancouver

Vo JB, Rosenberg S, Zhang BX, Snow C, Kirkner G, Poorvu PD, et al. Association of cancer treatment with excess heart age among five-year young breast cancer survivors. Journal of Cancer Survivorship. 2026;20(1):189-197. doi:10.1007/s11764-024-01645-9

BibTeX
@article{Vo2026,
  author = {Vo, Jacqueline B and Rosenberg, Shoshana and Zhang, Bessie X and Snow, Craig and Kirkner, Greg and Poorvu, Philip D and Gaither, Rachel and Ruddy, Kathryn J and Tamimi, Rulla M and Peppercorn, Jeffrey M and Schapira, Lidia and Borges, Virginia F and Come, Steven E and Nohria, Anju and Partridge, Ann H},
  title = {Association of cancer treatment with excess heart age among five-year young breast cancer survivors},
  journal = {Journal of Cancer Survivorship},
  year = {2026},
  volume = {20},
  number = {1},
  pages = {189--197},
  doi = {10.1007/s11764-024-01645-9}
}
Kostenlos starten →